Skip to main content
. Author manuscript; available in PMC: 2024 Oct 19.
Published in final edited form as: Pharmacol Ther. 2021 Mar 31;225:107844. doi: 10.1016/j.pharmthera.2021.107844

Fig. 2.

Fig. 2.

Summarized illustration of FLT3 targeting CAR T-Cells (A) FLT3 CAR T-cell targeting FLT3 antigen; (B) FLT3L CAR T-Cell is a second-generation CAR T cells where the extracellular domain is the FLT3 ligand (FL) while 4–1BB and CD3ζ are the intracellular signal domains; (C) Bispecific FLT3 and WT-1 CAR T-cell that target the FLT3-ITD mutation and WT-1 mutation which has been demonstrated to be associated with FLT3-ITD mutations.